Let's see whats new in the market
Bruker and the Karlsruhe Institute of Technology (KIT), Germany announced on August 5th the successful installation of the 15.2 Tesla ultra-high field magnetic resonance (MR) imaging system, BioSpec© 152/11. The BioSpec system enables new science at the KIT’s Institute of Microstructure Technology (IMT) under the direction of Professor Jan Korvink. Korvink’s group focuses on the development of novel MRI concepts leading to two visionary goals for the BioSpec: to increase automation of MRI scans, enabling a higher throughput; and to correlate measurements from multiple analytical techniques, increasing information content while decreasing measurement time.
Dräger will help protect thousands of firefighters, first responders, and fire industry professionals with American-made N95 disposable respirators during FDIC International. Made by American workers in Pennsylvania, the Dräger X-plore 1750 will be distributed throughout FDIC at the Indiana Convention Center and Lucas Oil Stadium during the exposition as well as during educational classes and at large gatherings. Dräger is supplying tens of thousands of individually wrapped, fold flat N95 respirators to attendees as the official provider of N95 respirators to FDIC.
SIGA Technologies, Inc., a commercial-stage pharmaceutical company focused on the health security market, today announced that it has entered a collaboration with Oxford University in the United Kingdom to provide TPOXX® (tecovirimat) under an expanded access protocol to treat individuals affected by monkeypox in the Central African Republic (CAR). Under the agreement, Oxford University will sponsor the protocol and study in CAR, and SIGA will provide up to 500 courses of TPOXX (tecovirimat) at no cost.
Thermo Fisher Scientific, the world leader in serving science, lately announced it has updated its Applied Biosystems TaqMan SARS-CoV-2 Mutation Panel to detect the Delta and Lambda strains. First launched in March 2021, the research panel features a customizable menu of verified real-time PCR assays for the identification of SARS-CoV-2 mutations. The panel enables laboratories to track known mutations by selecting from a menu of over 50 assays designed to screen for different variants. The TaqMan SARS-CoV-2 Mutation Panel is highly scalable, allowing up to hundreds of samples to be run to identify one or multiple mutations so labs can scale their surveillance operations based on testing needs.
Teledyne FLIR, part of Teledyne Technologies Incorporated (NYSE:TDY), today introduced the Neutrino SX8 mid-wavelength infrared (MWIR) camera module and four additional Neutrino IS Series models designed for integrated solutions requiring HD MWIR imagery with size, weight, power, and cost (SWaP+C) constraints for commercial, industrial, defense original equipment manufacturers (OEM), and system integrators. Based on Teledyne FLIR HOT FPA technology, the Neutrino SX8 offers high-performance, 1280x1024 HD MWIR imagery for ruggedized products requiring long life, low power consumption, and quiet, low vibration operation. The SX8 and the Neutrino IS series models are ideal for integration with small gimbals, airframes, handheld devices, security cameras, targeting devices, and asset monitoring applications.
Environics Oy and the National Police Board of Finland have signed a delivery and maintenance agreement for radiation detection and identification equipment. Environics delivers its Radionuclide Identifier Backpacks, high performance and simple devices for radionuclide search, identification & location. The National Police Board of Finland’s tasks include planning, directing, developing, and supervising police operations and the related support functions. In addition, it is responsible for the equal availability of police services nationwide, decides on cooperation between police units and is in charge of their performance management.
Paratek Pharmaceuticals, Inc., (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use, today announced that the U.S. Food and Drug Administration (FDA) has granted the company orphan drug designation for NUZYRA® (omadacycline) for the treatment of infections caused by Nontuberculous Mycobacteria (NTM). This orphan drug designation includes NTM pulmonary disease caused by Mycobacterium abscessus complex (MABc), which is the focus of an ongoing Phase 2b study initiated by Paratek.
The European leading robotics and autonomous systems developer Milrem Robotics exhibited their Intelligent Functions off-road capabilities at the first demonstration of iMUGS, the project to develop the European standard unmanned ground vehicle. The autonomy demonstration was performed using two THeMIS unmanned ground vehicles. First, one THeMIS UGV followed a human operator walking along a path with various obstacles. Second, the operator took control of the first UGV using Line of Sight (LoS) control and set the second THeMIS to follow the first one from waypoint A to B. After a successful performance, the second THeMIS was commanded to return home via Milrem’s Intelligent Functions Integration Kit’s (MIFIK) Mission Planner. While en route, the operator stepped in front of the UGVs path to trigger its obstacle detection and an auto-stop feature. After the operator had passed through the UGVs path, the vehicle continued its way to its home point.